Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Jan 29, 2015 at 10:45 AM EST

Is Celgene’s Outlook Good Enough for Investors?

Celgene Corp. (NASDAQ: CELG) reported better-than-expected fourth-quarter earnings on Thursday morning.

Chris Lange | Jan 28, 2015 at 11:00 AM EST

Short Sellers Starting to Gang Up on Biotech

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. For the majority of the selected…

Lee Jackson | Jan 28, 2015 at 10:45 AM EST

5 Stocks That May Benefit From a Terrible Flu Season

Here are five stocks rated Outperform at Baird that are seeing a high percentage of pulmonary Medicare admissions.

Chris Lange | Jan 27, 2015 at 8:20 AM EST

Pfizer Faces Reality Check With Earnings

Pfizer reported better-than-expected fourth-quarter earnings Tuesday before the U.S. markets opened.

Jon C. Ogg | Jan 26, 2015 at 4:53 PM EST

Is a Generic Nexium Purple Pill for You?

Teva Pharmaceutical announced on Monday that the FDA approved the first generic equivalent to Nexium delayed-release capsules in the United…

Douglas A. McIntyre | Jan 26, 2015 at 6:41 AM EST

American Obesity Rate Tops 27%

Heart disease, obesity and diabetes have become epidemics in America. The drag on the American health industry and the overall…

Lee Jackson | Jan 22, 2015 at 9:15 AM EST

3 Biotech Stocks With Upcoming Data That Could Be Huge

A new report from RBC focuses on top small-cap biotech stocks with key data readouts coming in 2015. Binary events…

Douglas A. McIntyre | Jan 22, 2015 at 6:48 AM EST

Can Twitter Predict Heart Disease?

In a study about how activity on Twitter can predict health outcomes, researchers found tweets on the social network can…

Paul Ausick | Jan 21, 2015 at 7:55 AM EST

UnitedHealth Earnings Rise as Insurer Adjusts to Obamacare

UnitedHealth Group reported better than expected fourth-quarter and full-year 2014 results before markets opened Wednesday morning.

Douglas A. McIntyre | Jan 21, 2015 at 6:45 AM EST

Oil Price Collapse Hurting Some More Than Others

A new Wood Mackenzie report paints a complex picture of what to expect in 2015. The report identifies several trends…

Chris Lange | Jan 20, 2015 at 8:30 AM EST

Johnson & Johnson Barely Pulls Through on Strong Pharma Sales

Johnson & Johnson reported better than expected fourth-quarter results Tuesday before the market open.

Paul Ausick | Jan 18, 2015 at 8:20 AM EST

Merck Is Top DJIA Stock in 2015

Merck shares posted a new 52-week high last Tuesday and closed Friday less than a buck from that high. Year…

Chris Lange | Jan 15, 2015 at 2:00 PM EST

Has eHealth Fallen Too Far?

eHealth was devastated in Thursday’s trading as the company announced its preliminary results for its fourth quarter.

Chris Lange | Jan 14, 2015 at 5:01 PM EST

Did Ziopharm and Intrexon Run Too Much on an MD Anderson Pact?

When two stocks run up over 50% and 30% on the same news, investors have to wonder if the move…

Chris Lange | Jan 13, 2015 at 8:55 AM EST

Short Interest in Biotechs Signals Optimism

24/7 Wall St. has reviewed the short interest in the top biotech companies, without focusing on speculative companies.

1 … 271 272 273 274 275 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Is Celgene’s Outlook Good Enough for Investors?

Short Sellers Starting to Gang Up on Biotech

5 Stocks That May Benefit From a Terrible Flu Season

Pfizer Faces Reality Check With Earnings

Is a Generic Nexium Purple Pill for You?

American Obesity Rate Tops 27%

3 Biotech Stocks With Upcoming Data That Could Be Huge

Can Twitter Predict Heart Disease?

UnitedHealth Earnings Rise as Insurer Adjusts to Obamacare

Oil Price Collapse Hurting Some More Than Others

Johnson & Johnson Barely Pulls Through on Strong Pharma Sales

Merck Is Top DJIA Stock in 2015

Has eHealth Fallen Too Far?

Did Ziopharm and Intrexon Run Too Much on an MD Anderson Pact?

Short Interest in Biotechs Signals Optimism

Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

Veteran Hedge Fund Manager: Anthropic Targets $500 Billion Market Opportunity as ‘Just Coding Alone Has Completely Taken Off’

New Inflation Data Confirms the end of Kevin Warsh’s Honeymoon

Fidelity’s 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

Fidelity's 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

74-Year-Old With $2.6M Discovers Late Husband's IRA RMD Doubled Her Tax Bill

Veteran Hedge Fund Manager: Anthropic Targets $500 Billion Market Opportunity as ‘Just Coding Alone Has Completely Taken Off’

New Inflation Data Confirms the end of Kevin Warsh’s Honeymoon

Health and Healthcare Articles

All Health and Healthcare Articles

Is Celgene’s Outlook Good Enough for Investors?

Short Sellers Starting to Gang Up on Biotech

5 Stocks That May Benefit From a Terrible Flu Season

Pfizer Faces Reality Check With Earnings

Is a Generic Nexium Purple Pill for You?

American Obesity Rate Tops 27%

3 Biotech Stocks With Upcoming Data That Could Be Huge

Can Twitter Predict Heart Disease?

UnitedHealth Earnings Rise as Insurer Adjusts to Obamacare

Oil Price Collapse Hurting Some More Than Others

Johnson & Johnson Barely Pulls Through on Strong Pharma Sales

Merck Is Top DJIA Stock in 2015

Has eHealth Fallen Too Far?

Did Ziopharm and Intrexon Run Too Much on an MD Anderson Pact?

Short Interest in Biotechs Signals Optimism

Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

Veteran Hedge Fund Manager: Anthropic Targets $500 Billion Market Opportunity as ‘Just Coding Alone Has Completely Taken Off’

New Inflation Data Confirms the end of Kevin Warsh’s Honeymoon

Fidelity’s 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

Featured Reads

Fidelity's 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

74-Year-Old With $2.6M Discovers Late Husband's IRA RMD Doubled Her Tax Bill